Enjoy complimentary customisation on priority with our Enterprise License!
The global cardiac restoration systems market size is estimated to grow by USD 190.53 million at a CAGR of 5.84% between 2023 and 2028.
Medical tourism refers to patients traveling to countries such as Singapore, Malaysia, Thailand, and India to obtain medical treatment with high-quality healthcare, affordability, and accessibility benefits. Emerging economies are increasingly becoming destinations for medical tourists seeking cardiac restoration procedures. These countries may offer cost-effective healthcare options compared to developed nations. As a result, the patient pool for cardiac restoration systems in emerging economies can expand significantly. Emerging economies such as India are investing in state-of-the-art healthcare facilities and technology to attract medical tourists. Medical tourism is a booming industry, as each medical expertise is focused on offering niche services to attract foreign patients. Thus, the rise in the quality of medical services and infrastructure in developing economies is a contributor to the growth of medical tourism, which will drive the growth of the cardiac restoration systems market during the forecast period.
Technavio has segmented the market into end-user, product and geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 to 2022, besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
The market share growth by the hospitals segment will be significant during the forecast period. Hospitals are specialized healthcare institutions that offer best-in-class diagnosis and treatment services to patients with acute and complex conditions. Hospitals include both multispecialty hospitals and general government hospitals where patients with different types of diseases, including CVDs, are diagnosed and treated.
Get a glance at the market contribution of various segments View a PDF Sample
The hospitals segment was the largest and was valued at USD 207.03 million in 2018. Hospitals usually procure cardiac restoration systems in bulk at a better cost structure through bidding from cardiac restoration systems manufacturers and suppliers. Mid-sized and small-sized hospitals have fewer supplier groups; unlike large hospitals, the administration of these hospitals is often decentralized. Mid-sized hospitals are easily accessible to people, and their number is higher than that of large hospitals. Mid-sized hospitals (accommodating 200-300 beds) are key end-users in the global cardiac restoration systems market. They depend more on local suppliers than key vendors since local vendors provide low-cost products. Thus, these factors will contribute to the growth of the hospital segment, which will boost the growth of the global cardiac restoration systems market during the forecast period.
Mitral valve restoration systems are effective in treating patients with severe mitral valve regurgitation conditions, where the posterior leaflet is partially or completely dysfunctional or destroyed. One of the primary advantages of mitral valve restoration systems is that they aim to preserve the patient natural mitral valve. Moreover, mitral valve restoration procedures are often less invasive than valve replacement surgeries. As a result, patients may experience shorter hospital stays and quicker postoperative recoveries, allowing them to return to their normal activities sooner. Thus, factors such as preservation of natural valve function with improved valve function will contribute to the growth of the mitral valve restoration systems segment, which will boost the growth of the global cardiac restoration systems market during the forecast period.
Left ventricular restoration systems are less invasive devices used to reduce left ventricular volume and restore heart geometry. The primary goal of left ventricular restoration systems is to enhance the function of the left ventricle, which is responsible for pumping oxygenated blood to the rest of the body. Conventionally, left ventricular restoration devices are used with surgical interventions such as partial left ventriculostomy and surgical ventricular restoration. However, in recent times, left ventricular restoration devices have been used as standalone devices, which has resulted in a rise in the adoption of these restoration systems. Thus, these factors will promote the growth of the left ventricular restoration systems segment, which will propel the growth of the market in focus during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The cardiac restoration systems market in North America was driven by the presence of well-equipped and established healthcare infrastructure, the availability of highly skilled professionals, and the presence of extensive healthcare insurance coverage. In addition, increasing R&D expenditure of vendors, high adoption of technologically advanced products, and the availability of less invasive treatments are contributing to the market growth in North America. The US is the major revenue contributor to the market in North America, owing to extensive healthcare insurance coverage from the Centers for Medicare and Medicaid Services (CMS).
In addition, the strong presence of well-established medical and healthcare infrastructure, the growing ageing population, and the rising incidence of CVDs such as mitral valve regurgitation and ischemic heart disease in the US are contributing to the market growth in North America. According to the CDC, every year, one out of four mortalities occur in the US due to heart disease. Furthermore, the increasing medical tourism for performing minimally invasive cardiac procedures due to the availability of low-cost treatment, highly skilled surgeons, and high-quality services is also driving the growth of the cardiac restoration systems market in the country. Such factors are expected to drive market growth in the region during the forecast period.
The outbreak of COVID-19 in 2020 negatively impacted the regional cardiac restoration systems market. However, in 2021, due to mass vaccination drives and the lifting of lockdown restrictions, the growth of the market in focus was accelerated. Furthermore, in countries like the United States and Canada, health insurance coverage is prevalent, ensuring that a large portion of the population can access cardiac restoration procedures and devices without significant financial barriers. Such factors are expected to drive the growth of the market in focus in the region during the forecast period.
Buy Now Full Report and Discover More
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 10 market companies, including:
Ancora Heart Inc. - The company offers cardiac restoration systems such as Mitraclip Transcatheter Mitral Valve Repair which delivers a minimally invasive treatment option for patients with primary or secondary mitral regurgitation.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges.
Rising healthcare expenditure is notably driving market growth. High healthcare expenditure can lead to the availability of more advanced cardiac procedures and treatments. Healthcare infrastructure, including the construction of specialized cardiac centers and hospitals, may receive increased investment. These facilities often require the latest cardiac restoration equipment, contributing to market growth. Increased healthcare spending can accelerate technological advancements in the field of cardiac restoration systems. Manufacturers may have more resources to invest in research and innovation.
Moreover, healthcare expenditure can fund training programs and educational initiatives for healthcare professionals specializing in cardiac care since well-trained professionals are essential for the effective use of cardiac restoration systems. Thus, rising healthcare expenditure will impel the growth of the global cardiac restoration systems market during the forecast period.
Growing awareness about cardiac restoration systems is an emerging trend shaping the market growth. The increasing incidence of heart valve diseases, such as mitral valve regurgitation, has led to an increase in awareness about cardiac restoration systems. Initiatives to raise awareness about heart valve diseases are held through conferences and hosting programs, which emphasize early diagnosis and treatment with cardiac restoration systems. Furthermore, companies are organizing campaigns to raise awareness among people about heart valve diseases. Players in the global cardiac restoration systems market are also aimed at conducting programs regularly to introduce their new product briefings and to create awareness about advanced treatment solutions available in the market.
For instance, in November 2021, Xeltis announced its plan to accelerate its clinical trial program for three restorative devices in parallel. Therefore, the rising awareness about cardiac restoration systems is expected to propel the growth of the market during the forecast period.
A shortage of cardiologists is a major challenge hindering the market growth. Knowledge and skill in handling and using diagnostic and therapeutic tools play a major role in the early diagnosis and treatment of various CVDs. The lack of expertise increases the probability of misdiagnosis and improper treatment, which can have harmful effects on patients. The clinical practice of cardiologists is changing due to the emergence of new technologies. Cardiovascular surgical procedures such as surgical ventricular restoration require high technical and non-technical abilities to provide improved treatment.
However, the market has a shortage of skilled cardiologists for performing cardiac restoration surgical interventions. The increasing rates of burned-out professionals also lead to a shortage of skilled professionals. Hence, the shortage of cardiologists can hinder the growth of the global cardiac restoration systems market during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Cardiac Restoration Systems Market Customer Landscape
The cardiac restoration systems market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.
Cardiac Restoration Systems Market Scope |
|
Report Coverage |
Details |
Page number |
154 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.84% |
Market Growth 2024-2028 |
USD 190.53 million |
Market structure |
Concentrated |
YoY growth 2023-2024(%) |
4.8 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 40% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Ancora Heart Inc., Artivion Inc., Baxter Regional Medical Center, BioVentrix Inc., Edwards Lifesciences Corp., Medtronic Plc, NeoChord Inc., Syntach AB, Xeltis AG, and Abbott Laboratories |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.